Onderneming Phoenix Life Sciences International Limited Other OTC
Aandelen
PLSI
US71910Q1022
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Lewis Humer
CHM | Chairman | 65 | 25-04-14 |
Stephen Cornford
CIO | Chief Investment Officer | - | - |
David Steinman
LAW | General Counsel | - | 01-02-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lewis Humer
CHM | Chairman | 65 | 25-04-14 |
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 084 582 | 8 644 192 ( 85,72 %) | 0 | 85,72 % |
Bedrijfsgegevens
Phoenix Life Sciences International Ltd.
1810 East Sahara Avenue Suite 215
89139, Las Vegas
+
http://www.phoenixlife.coSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+45,82% | 765 mld. | |
+40,95% | 632 mld. | |
-6,16% | 354 mld. | |
+19,86% | 331 mld. | |
+9,32% | 299 mld. | |
+18,45% | 248 mld. | |
-0,78% | 219 mld. | |
+11,88% | 216 mld. | |
+5,90% | 164 mld. |